Pain Market Research Reports & Industry Analysis
In considering the IASP definition, it is important to note that not all potentially tissue-damaging stimuli result in pain. Nociception is the activation of the primary afferent nerves with peripheral terminals that respond differently to noxious stimuli. Nociceptors function primarily to sense and transmit pain signals. Nociception may or may not be perceived as pain, depending on a complex interaction within the nociceptive pathways. If nociceptive stimuli are blocked, pain is not perceived. Finally, it is important to distinguish pain, or nociception, from suffering. Suffering is the state of severe distress associated with events that threaten the intactness of the person. Suffering is an emotion. Pain and suffering are not the same phenomenon.
The person who complained of pain in the heart because of the death of a loved one is suffering rather than experiencing pain as it is defined by the IASP. It is clear that three conditions could exist: 1) suffering occurs in the presence of pain,2) suffering occurs when pain is not present, and 3) pain occurs when suffering is not present. For example, the woman awaiting breast biopsy may suffer because of anticipated loss of her breast. After the biopsy, she may have pain without suffering if the biopsy is negative or pain with suffering if the biopsy is positive for malignancy. Interventions aimed at relieving pain and suffering may have some commonalities, but clearly some interventions for suffering will be inadequate for pain just as some interventions for pain are inadequate for suffering.
Pain Industry Research & Market Reports
-
Pain Management Devices Market
... and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Pain management devices include those for cancer pain, nociceptive ... Read More
-
Global Neuropathic Pain Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... global Neuropathic Pain market reached a value of USD 9263.0 million in 2022. It’s expected that the market will achieve USD 12324.0 million by 2028, exhibiting a CAGR of 4.87% during the forecast period. Limitations ... Read More
-
Pain Management Drugs Market Size - By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine), Indication (Arthritic, Neuropathic, Cancer), Pain Type (Chronic, Acute), Distribution Channel (Hospital, Retail, Online), Global Forecast (2023 - 2032)
... Market size is poised to record 4.5% CAGR from 2023-2032. The scaling R&D investments by pharmaceutical companies for creating novel pain management drugs and formulations for enhanced efficacy and reduced side effects will drive the ... Read More
-
Asia Gout Disease Treatment Market
... By Country (China, India, Japan, South Korea, Thailand, Indonesia, Singapore, Vietnam, and Rest of Asian Countries) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Gout is a chronic disease characterized by pain and ... Read More
-
Neuropathic Pain Market
... Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Neuropathic pain is a condition which involves pain caused due to damage or diseases ... Read More
-
2023 Global: Lower Back Pain Market - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
-
Monoclonal Antibodies In Veterinary Health Market Size, Share & Trends Analysis Report By Application (Dermatology, Pain), By Animal Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030
... Growth & Trends The global monoclonal antibodies in veterinary health market size is expected to reach USD 2.42 billion by 2030, expanding at a CAGR of 17.1% from 2023 to 2030, according to a new ... Read More
-
Topical Pain Relief Market by Therapeutic Class (Non-Opioids and Opioids), Formulation (Cream, Gel, Spray, Patch, and Others), Type (Prescription Pain Relief and Over-the-Counter Pain Relief), and Distribution Channel (Pharmacies & Drug Stores, E-Commerce, and Retail & Grocery Stores): Global Opportunity Analysis and Industry Forecast,2027
... & Grocery Stores): Global Opportunity Analysis and Industry Forecast,2027 The topical pain relief market refers to the market for products that are applied externally to alleviate pain and discomfort. These products typically come in the ... Read More
-
Pharmacogenomics Market by Technology (Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, and Others), Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Pain Management, and Others), and End User (Hospitals & Clinics, Research Institutions and Academic Institutes and Others): Analysis and Industry Forecast, 2027
... Institutions and Academic Institutes and Others): Analysis and Industry Forecast, 2027 The pharmacogenomics market refers to the market for diagnostic tests and technologies used to study an individual's genetic makeup and how it affects their ... Read More
-
Cluster Headache Market by Drug class (Ergot derivatives, Calcium channel blockers, Triptans and Others), Distribution channel (Hospital pharmacies, Drug stores and retail pharmacies and Others), Type (Episodic and Chronic) and Geography (North America, Europe, Asia Pacific and RoW) – Forecast up to 2027
... Pacific and RoW) – Forecast up to 2027 The most common types of primary headaches are cluster headaches which are known as trigeminal autonomic cephalgia. These cluster headaches can come every other day, one to ... Read More
-
North America Analgesics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 28.4 Billion by 2028, exhibiting a growth rate (CAGR) of 3.2% during 2023-2028. An analgesic or painkiller is any member of the group of drugs used for achieving analgesia or relief from pain. ... Read More
-
Clinical Trials Market Forecast to 2028 - Global Analysis by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular Disease, and Others)
... Diabetes, Obesity, Cardiovascular Disease, and Others) The clinical trials market size is expected to reach US$ 25,476.86 million by 2028 from US$ 17,343.46 million in 2022; it is estimated to record a CAGR of 6.8% ... Read More
-
Clinical Trials Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular Disease, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular Disease, and Others) The clinical trials market size is expected to reach US$ 25,476.86 million by 2028 from US$ 17,343.46 million in 2022; it is estimated to record a ... Read More
-
2023 Global Forecast for Pain Management Devices Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx ... Read More
-
2023 Global Forecast for Pain Management Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2024 ... Read More
-
Global Self-injection Devices Market Size study & Forecast, by Product (Autoinjectors, Pen Injectors, Wearable Injectors, Needle-free Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Autoimmune Disorders, Hormonal Disorders, Pain Management, Others) and Regional Analysis, 2023-2030
... Global Self-injection Devices Market is valued at approximately USD 6.98 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period 2023-2030. Self-injection devices, also ... Read More
-
Global Autoinjectors Market (4th Edition), 2021-2035 Distribution by Type of Autoinjector (Disposable and Reusable), Route of Administration (Subcutaneous and Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Therapeutic Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts
... Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts According to the National Health Interview Survey (NHIS), nearly 52% of the adult ... Read More
-
2023 Global Forecast for Patient-Controlled Analgesia (Pca) Pump Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD ... Read More
-
Fibromyalgia- Pipeline Insight, 2023
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Fibromyalgia: Understanding Fibromyalgia: Overview ... Read More
-
Spinal Fusion Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
... and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Spinal Fusion pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Global Paracetamol and Caffeine Tablets Market Growth 2023-2029
... at a CAGR of % from 2023 to 2029. United States market for Paracetamol and Caffeine Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of ... Read More
-
Global Pain Management Devices Market - 2023-2030
... The global pain management devices market is expected to exhibit a CAGR of 7.1% during the forecast period (2023-2030). Pain management is a discipline of medical science that aids in the relief of chronic pain ... Read More
-
Global Opioids Drug Market - 2023-2030
... opioids drug market is expected to exhibit a CAGR of 3.3% during the forecast period (2023-2030). Opioid drugs are commonly prescribed for the management of moderate to severe pain, particularly acute pain following surgeries or ... Read More
-
2023 Global Forecast for Over The Counter (Otc) Analgesics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
North America Synthetic Opioids Market
... and Hospitals), and By Country (U.S. and Canada)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Synthetic opioids are a class of medication that are created in labs with a specific chemical structure. The ... Read More
Research Assistance
